Trials / Completed
CompletedNCT01712360
Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis
An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of NAFT-500 in Pediatric Subjects With Tinea Cruris and Tinea Pedis and NAFT-600 in Pediatric Subjects With Tinea Pedis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to see how the body is affected when a study drug is applied to both feet if the subject has athlete's foot or to both feet and the groin area if the subject has both athlete's foot and jock itch. Safety of the drug and how well the drug works will also be measured.
Detailed description
Study population, diagnosis, and main criteria for inclusion: Tinea pedis and Tinea cruris (NAFT-500): Male or non-pregnant female subjects aged 12 to 17 years, 11 months old of any race with Tinea pedis and Tinea cruris infections confirmed by a positive potassium hydroxide (KOH) analysis from both the feet and bikini area. Both cases (feet and bikini area) must be characterized by clinical evidence of a Tinea pedis and Tinea cruris infection. Additional, approximately 4 pharmacokinetic (PK) evaluable adult subjects with the same condition will serve as a control. Tinea pedis (NAFT-600): Male or non-pregnant female subjects aged 12 to 17 years, 11 months old of any race with Tinea pedis infection confirmed by a positive potassium hydroxide (KOH) analysis from both feet. Both feet must be characterized by clinical evidence of a Tinea pedis infection. Additional, approximately 4 pharmacokinetic (PK) evaluable adult subjects with the same condition will serve as a control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NAFT500 (pediatric) | Applied to both feet and groin area |
| DRUG | NAFT600 (pediatric) | Applied to both feet only |
| DRUG | NAFT500 (adult) | Applied to both feet and groin area |
| DRUG | NAFT600 (adult) | Applied to both feet |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-10-23
- Last updated
- 2016-07-14
- Results posted
- 2016-07-14
Locations
4 sites across 3 countries: United States, Dominican Republic, Honduras
Source: ClinicalTrials.gov record NCT01712360. Inclusion in this directory is not an endorsement.